Oncotype testing
Ended Awarded Last action
- Contract number
- HT001419F0032
- Awardee
-
Genomic Health, Inc. UEI RHN3L7SBF7J6
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $120,889
Award facts
- Contract value 100% obligated
- $120,889.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Belvoir, VA 22060, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$59,111 | |
| Change Order | $0 | |
| Original award | $180,000 |
About this award
This federal contract award is for ONCOTYPE TESTING services provided by Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The $120,889 Firm Fixed Price contract was awarded by the Defense Health Agency, a component of the Department of Defense, on October 28, 2018. The contract has an ultimate completion date of October 28, 2019 and is a BPA Call, which allows the agency to order services on an as-needed basis.
Genomic Health is a leading provider of genomic-based cancer testing services to the federal government. This contract supports the agency's cancer screening, treatment selection, and disease monitoring programs at its facilities. Genomic Health has received numerous prime federal contracts for its Oncotype DX portfolio of assays, which analyze gene expression to determine cancer recurrence risk and predict treatment benefits. The contract does not utilize a set-aside designation, as Genomic Health provides proprietary testing services. Genomic Health maintains several large Indefinite Delivery Vehicles with agencies like the Defense Health Agency and Air Force for ongoing provision of its Oncotype DX cancer testing services.
Quick answers
Who was awarded contract HT001419F0032?
HT001419F0032 was awarded to Genomic Health, Inc. by Defense Health Agency (Department of Defense) on October 28, 2018.
How much is contract HT001419F0032 worth?
The government has obligated $120,889 on HT001419F0032.
Is contract HT001419F0032 an order under another contract?
Yes. HT001419F0032 is a BPA call under HT001416A0144, a blanket purchase agreement.
Was contract HT001419F0032 competed?
The extent of competition for HT001419F0032 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award